Recorded fact · drug.label_indication
drug.label_indication for empagliflozin|chronic-kidney-disease
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 874572b0 resolves to.
The record
| Fact id | 874572b09379b5f5d6d3eee8 |
|---|---|
| Entity | drug: empagliflozin|chronic-kidney-disease |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260617 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 22f05bbe7966f16a84594f366649905469556afe42ccf6952cdb371ebedfd2fb.
The value
{
"ingredient": "EMPAGLIFLOZIN",
"conditionId": "chronic-kidney-disease",
"conditionName": "Chronic Kidney Disease",
"matchedAlias": "chronic kidney disease",
"context": "risk-reduction",
"brand": "Jardiance",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "334f1b3d-5670-6685-e063-6294a90a7e47",
"labelEffectiveTime": "20260617",
"labelsRead": 9,
"labelsNaming": 4,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 81d3891060cdef5e5c12d6443cee4d652781e384e3e4ffedb69ef622e7324d81.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.